Dario Health Corp is a digital health company that focuses on providing innovative solutions for chronic disease management, particularly in the areas of diabetes, hypertension, and behavioral health. The company's platform combines connected devices, software applications, and personalized coaching to empower patients in managing their health more effectively. By leveraging advanced analytics and real-time data, Dario aims to enhance patient engagement and improve health outcomes, ultimately enabling individuals to take control of their chronic conditions through a more integrated and user-friendly approach. Read More
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million.
Shares of Top KingWin Ltd (NASDAQ: WAI) rose sharply in pre-market trading after the company announced it entered into a sales contract with Walker Times International for the sale of 10,000 units of TK-D2C AI Robots.
Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their outstanding shares is at $5.6 million.
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Groundbreaking Study Reveals Users Maintain Weight Loss and Blood Sugar Control After Stopping Medication; AI-Powered Platform Could Play a Major Role in $100 Billion Weight Management Market
DarioHealth (NASDAQ:DRIO) is emerging as a potential multi-bagger in digital health, leveraging AI, GLP-1 integration, and rising payer demand to disrupt a $4T+ chronic care market
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Market News Alerts Reports: DarioHealth Corp. (Nasdaq: DRIO)* emerges as a potential hidden gem in digital health as competitor Hinge Health prepares to go public at a multi-billion-dollar valuation, highlighting a dramatic valuation gap that savvy investors are beginning to notice. With Hinge Health filing for a potential April IPO at a valuation that according to recent reports could reach $3-6 billion despite recent market volatility, DarioHealth's comprehensive AI-driven chronic care platform appears to be potentially significantly undervalued by comparison.
Market News Alerts Updates: Market News Alerts Reports: DarioHealth Corp. (Nasdaq: DRIO) reported fourth quarter revenue of $7.6 million, beating analyst consensus of $7.39 million. B2B2C recurring revenue surged 398% year-over-year to $5.6 million in Q4, driven by rapid employer and health plan adoption of the company's comprehensive chronic care platform. Gross margins in the B2B2C business exceeded 80% over the past three quarters.
Market News Alerts Updates: DarioHealth Corp. (Nasdaq: DRIO)* has announced a significant new agreement with a Blue Cross Blue Shield (BCBS) health plan, marking a pivotal expansion in the fast-growing digital health landscape. This move integrates Dario's AI-driven cardiometabolic digital health solutions, covering diabetes, hypertension, and weight management, into the offerings of one of America’s most trusted health insurers. According to a recent report, the cardiometabolic disease market is projected to surpass $1.2 trillion by 2033.
PESG Releases Report: In a healthcare market brimming with potential, DarioHealth Corp. (Nasdaq: DRIO)* is quietly emerging as a standout player, combining cutting-edge technology with proven outcomes. Looking at recent achievements, it seems DarioHealth’s multi-condition digital health platform and its accelerating financial trajectory may position it as a sleeper hit in a rapidly growing sector.
